Filing Details

Accession Number:
0001209191-22-008267
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-02-09 21:00:29
Reporting Period:
2022-01-31
Accepted Time:
2022-02-09 21:00:29
Original Submission Date:
2022-02-02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899460 Mannkind Corp MNKD Pharmaceutical Preparations (2834) 133607736
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1674282 Michael Castagna 30930 Russell Ranch Road
Suite 300
Westlake Village CA 91362
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2022-01-31 1,804 $3.17 1,505,098 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2022. The amended number of shares purchased were limited by Section 423(b)(8) of the Code.